Keeping it simple is the cornerstone of IES Patient Comfort Systems, whose products quiet patient movement with the squishable innards found in Tempur-Pedic beds.
Keeping it simple is the cornerstone of IES Patient Comfort Systems, whose products quiet patient movement with the squishable innards found in Tempur-Pedic beds.
Making patients comfortable during MR exams cuts the need for repeat scans and callbacks, according to Dr. Peter Rothschild, president and founder of the company based in Hayward, CA. Rothschild cites research to that effect conducted at the University of Louisville School of Medicine, where 200 lumbar MR exams were conducted using traditional pads and another 100 done using the new IES Patient Comfort Systems pads.
When traditional pads were used, motion artifacts caused at least one sequence to be repeated in 18% of the scans, and the entire procedure to be redone in 8%. When IES Patient Comfort Systems' pads were introduced, only 8% required a repeat sequence, and just 4% needed repetition of the entire exam. The researchers concluded that the pressure-managing Tempur material led to decreased patient motion, which boosted throughput and reduced patient callbacks.
Hoping to damp out motion well outside a research setting, IES Patient Comfort Systems offers a wide array of pads and positioners, including a knee wedge. The pads are in use at two imaging centers in Elkhart and Goshen, IN, that specialize in large patients, providing open systems to accommodate them.
"These pads are really good for them," said owner Randal Kostka, a technologist by training. "In open MR, the patient has to lie on the table a little longer than in a tube."
Other products in the IES Patient Comfort pipeline include earmuffs for deadening the noise of MR and an assembly of pads that guides dynamic MR study, causing the neck to change position, as one pad after the other is removed.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.